文献速递糖尿病

SLC19A2变异在非自身免疫性血糖稳态异常广谱表现中的作用

The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis.
PubMed 文献 · Diabetologia · 2025-07-02

本研究通过对两个轻度高血糖先证者家系行全外显子组测序及英国生物银行191,140例样本分析,发现两个不同的SLC19A2杂合错义可能致病变异与非综合征性轻度高血糖相关;携带额外单基因糖尿病基因变异的个体发病提前25-31年;12个罕见无效变异与2型糖尿病相关(p=0.00033;OR 3.7;95% CI 1.3, 227)并升高HbA1c(p=0.019,效应[π]=2.2 ± 0.92)。

要点

  • 两个家系中SLC19A2杂合错义可能致病变异(c.515G>T和c.1063A>C)与非综合征性轻度高血糖相关。
  • 携带PDX1或KCNJ11额外变异的个体疾病发病提前25-31年。
  • 英国生物银行中12个SLC19A2罕见无效变异与2型糖尿病相关(p=0.00033;OR 3.7;95% CI 1.3, 227)。

核心结论

  • SLC19A2变异可调节血糖稳态,涵盖隐性综合征性糖尿病、常染色体显性轻度高血糖至2型糖尿病。

研究设计与样本

  • 对两个轻度高血糖先证者及英国生物银行191,140例样本行全外显子组测序。

主要发现

  • 两个家系中SLC19A2杂合错义可能致病变异(c.515G>T和c.1063A>C)与非综合征性轻度高血糖相关。
  • 两个家系中携带PDX1(NM_000209.3)或KCNJ11(NM_000525.3)额外变异的个体发病提前25-31年。
  • 英国生物银行中12个SLC19A2罕见无效变异与2型糖尿病相关(p=0.00033;OR 3.7;95% CI 1.3, 227)。
  • 英国生物银行中12个SLC19A2罕见无效变异与HbA1c升高相关(p=0.019,效应[π]=2.2 ± 0.92)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Biallelic pathogenic variants in SLC19A2 (the solute carrier family 19 member 2, which encodes thiamine transporter 1, responsible for thiamine intake) cause a recessive syndromic diabetes of infancy or early childhood in the context of thiamine-responsive megaloblastic anaemia, characterised by sensorineural deafness. Indeed, it has been reported, although only once, that even a heterozygous missense loss-of-function variant of SLC19A2 causes dominantly inherited non-syndromic diabetes. Finally, it is unknown whether rare SLC19A2 pathogenic variants modulate the risk of type 2 diabetes at the population level. We investigated the role of SLC19A2 heterozygous variants in both autosomal dominant mild hyperglycaemia and type 2 diabetes. METHODS: We performed whole exome sequencing in two probands with mild hyperglycaemia and in 191,140 samples from the UK Biobank. RESULTS: Here we report two different heterozygous missense likely pathogenic variants of SLC19A2 (NM_006996.2) associated with non-syndromic mild hyperglycaemia in two pedigrees (c.515G>T and c.1063A>C missense variants, respectively), clearly confirming the only report available so far suggesting this link. In both pedigrees, individuals who carried an additional variant in one of the established monogenic diabetes genes (i.e. PDX1, NM_000209.3 and KCNJ11, NM_000525.3) showed an anticipation of disease onset of 25-31 years. Finally, 12 rare null variants in SLC19A2 were associated with type 2 diabetes (p=0.00033; OR 3.7; 95% CI 1.3, 227) and increased HbA1c levels (p=0.019, effect [π]=2.2 ± 0.92) in the UK Biobank. CONCLUSIONS/INTERPRETATION: Taken together with previous evidence, these data indicate that SLC19A2 variability modulates glucose homeostasis, from recessive syndromic diabetes, to autosomal dominant mild hyperglycaemia, to type 2 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Marucci A, Derhourhi M, Menzaghi C, et al. The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis. Diabetologia. 2025. PMID: 40603556. doi:10.1007/s00125-025-06485-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。